David N. Schidlow

David N. Schidlow

Auto-generated profile, based on publicly available information

David N. Schidlow

Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2011 in Congenital Heart Disease
Verified
Journal Article
Closed access
PDF file
DSDavid N. Schidlow
David N. Schidlow
JAJeffrey B. Anderson
Jeffrey B. Anderson
TKThomas S. Klitzner
Thomas S. Klitzner
RIRobert H. Beekman Iii
Robert H. Beekman Iii
KJKathy J. Jenkins
Kathy J. Jenkins
FCFor the JCCHD National Pediatric Cardiology Quality Improvement Collaborative
For the JCCHD National Pediatric Cardiology Quality Improvement Collaborative
The National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) is the first quality improvement collaborative in pediatric cardiology, and its registry captures information on interstage care and outcomes of infants after the Norwood procedure. The purpose of this study was to evaluate variation in interstage outpatient clinical care practices for infants discharged home after the Norwood procedure. Data for the first 100 infants enrolled in the NPC-QIC registry were evaluated. The care domains assessed for variation included: (1) discharge communication with outpatient cardiologist and primary care physician (PCP); (2) nutrition plan at hospital discharge; and (3) planned use of home surveillance strategies. One hundred infants were discharged home between July 2008 and February 2010, from 21 participating US pediatric cardiac programs. Median age at discharge was 29 (11-188) days. Interstage outpatient care was provided at the Norwood center for 62 infants, at other centers for 25, and at a combination of centers for 13. Complete discharge communication (defined as written communication of medication list, nutrition plan, and red flag checklist) was relayed to only 45 outpatient cardiologists and to 26 PCPs. Nutrition route at discharge was exclusively oral in 49, combined oral and nasogastric (NG)/nasojejunal (NJ) in 38, exclusively NG/NJ in six, combined oral and gastrostomy tube (GT) in six, and exclusively GT in one infant. Home surveillance strategies were utilized for 81 infants (oximetry and weight monitoring in 77, oximetry alone in four), with no home surveillance in 19 infants. Considerable variation exists in interstage outpatient care after the Norwood procedure in the care domains of discharge communication, nutrition, and home surveillance. Standardizing care around evidence-based practices may improve the outcomes for these very high-risk children.

12 June 2014 in American Journal of Perinatology
Verified
Journal Article
Closed access
PDF file
WTWayne Tworetzky
Wayne Tworetzky
LWLouise E. Wilkins-Haug
Louise E. Wilkins-Haug
DSDavid N. Schidlow
David N. Schidlow
Introduction Prenatal diagnosis provides valuable information regarding a variety of congenital heart defects. Some defects occur early in gestation with little change throughout pregnancy, whereas others evolve during mid and late gestation. Fetal cardiac intervention (FCI) affords the opportunity to interrupt progression of disease in this latter category, resulting in improved perinatal and lifelong outcomes. Aim This chapter addresses three lesions for which percutaneous FCI can be utilized: (1) aortic stenosis with evolving hypoplastic left heart syndrome, for which aortic valvuloplasty may prevent left ventricular hypoplasia and has yielded a biventricular circulation in approximately one third of cases; (2) hypoplastic left heart syndrome with intact atrial septum, for which relief of atrial restriction has potential to improve perinatal survival; and (3) pulmonary atresia with intact ventricular septum and evolving right ventricular hypoplasia, for which pulmonary valvuloplasty has resulted in a biventricular circulation in the majority of patients. The pathophysiology, rationale for intervention, patient selection criteria, procedural technique, and outcomes for each lesion will be reviewed. This chapter will also review complications of FCI and their treatment, and maternal and fetal anesthesia specific to FCI. The importance of a specialized center with experience managing infants delivered after FCI will also be addressed.

29 December 2017 in Echocardiography
Verified
Journal Article
Closed access
PDF file
DSDavid N. Schidlow
David N. Schidlow
LFLindsay Freud
Lindsay Freud
KFKevin Friedman
Kevin Friedman
WTWayne Tworetzky
Wayne Tworetzky

9 August 2014 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
DSDavid N. Schidlow
David N. Schidlow
KGKimberlee Gauvreau
Kimberlee Gauvreau
MPMehul Patel
Mehul Patel
KUKaren Uzark
Karen Uzark
DBDavid W. Brown
David W. Brown

20 August 2019 in JACC
Verified
Journal Article
Closed access
DSDavid N. Schidlow
David N. Schidlow
KGKimberlee Gauvreau
Kimberlee Gauvreau
KCK.M. Cherian
K.M. Cherian
XDXinwei Du
Xinwei Du
MKMahesh Kappanayil
Mahesh Kappanayil
KJKathy J. Jenkins
Kathy J. Jenkins

15 March 2024 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
DLDavid Liddle
David Liddle
AGAddison Gearhart
Addison Gearhart
LSLynn A. Sleeper
Lynn A. Sleeper
MLMinmin Lu
Minmin Lu
EFEric Feins
Eric Feins
RBRebecca Beroukhim
Rebecca Beroukhim
Background: Identification of risk factors for biventricular (BiV) repair in children with hypoplastic left ventricles (HLV) has been challenging. We sought to identify preoperative cardiovascular magnetic resonance (CMR) predictors of outcome in patients with HLVs who underwent BiV repair, with a focus on the mitral valve (MV). Methods: Single-center retrospective analysis of preoperative CMRs on patients with HLV (<= 50 mL/m2) and no endocardial fibroelastosis who underwent BiV repair from 2005-2022. CMR measurements included MV orifice area in diastole. The primary composite outcome included time to death, transplant, BiV takedown, heart failure admission, left atrial decompression, or unexpected reoperation; and the secondary outcome included more than or equal to moderate mitral stenosis and/or regurgitation. Results: Median follow-up was 0.7 (interquartile range 0.1, 2.2) years. Of 122 patients [59 atrioventricular canal (AVC) and 63 non-AVC] age 3 +/- 2.8 years at the time of BiV repair, freedom from the primary outcome at 2 years was 53% for AVC and 69% for non-AVC (log rank p = 0.12), and freedom from the secondary outcome at 2 years was 49% for AVC and 79% for non-AVC (log rank p < 0.01). Independent predictors of primary outcome for AVC patients included MV orifice area z-score < -2 and transitional AVC; for non-AVC patients, predictors included MV orifice area z-score < -2, abnormal MV anatomy, and conal-septal ventricular septal defect. Independent predictors of secondary outcome for AVC patients included older age at surgery, transitional AVC, and transposition of the great arteries. Conclusion: In children with HLV, low MV orifice area and pre-existing MV pathology are risk factors for adverse outcome after BiV repair.